{"database": "openregs", "table": "federal_register", "rows": [["E6-5221", "Regulatory Site Visit Training Program", "Notice", "The Food and Drug Administration's (FDA's) Center for Biologics Evaluation and Research (CBER) is reannouncing the invitation for participation in its Regulatory Site Visit Training Program (RSVP). This training program is intended to give CBER's regulatory review, compliance, and other relevant staff an opportunity to visit biologics facilities. These visits are intended to allow CBER staff to directly observe routine manufacturing practices and to give staff a better understanding of the biologics industry, including its challenges and operations. This notice invites biologics facilities interested in participating in this program to contact CBER for more information.", "2006-04-11", 2006, 4, "https://www.federalregister.gov/documents/2006/04/11/E6-5221/regulatory-site-visit-training-program", "https://www.govinfo.gov/content/pkg/FR-2006-04-11/pdf/E6-5221.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration's (FDA's) Center for Biologics Evaluation and Research (CBER) is reannouncing the invitation for participation in its Regulatory Site Visit Training Program (RSVP). This training program is intended to give CBER's...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["E6-5221"], "units": {}, "query_ms": 2.545165829360485, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}